Livalo Articles
Regulatory briefs: Shire to dump ProAmatine after FDA moves; Kowa gets first European approval for pitavastatin
19 August 2010
Lilly gets rights to Marcadia's glucagon analogs; Abbott to market Kowa's Livalo in Australia and New Zealand
29 June 2010
Lilly in deal with Kowa to co-promote newly-approved statin Livalo in USA and commercialization rights for Latin America
24 December 2009
Kowa acquires ProEthic Pharma
11 August 2008
PIP recommendations from EMEA's PDCO
26 May 2008
Kowa Soyaku vows to enter top 20 Jap firms
2 October 2006
Japan stock market week to January 9
16 January 2006
New Chemical Entities in 2003
19 January 2004
Eisai's pravastatin generic sluggish
5 January 2004
Sankyo targeting 50% share of statins market
6 October 2003
Tokyo pharma stocks - week to Sept 15
22 September 2003
Sankyo files new form of Benicar with FDA
12 August 2002
Tokyo pharma stocks - week to May 27
3 June 2002
Stock Commentary - Tokyo
8 November 2001
Tokyo pharma stocks - week to November 5
7 November 2001
Stock Commentary - Europe
1 November 2001
Stock Commentary - Tokyo
1 November 2001
BioMerieux-Pierre Fabre licenses pitavastatin
31 October 2001
Tokyo pharma stocks - week to October 29
30 October 2001
Recordati licenses Kowa superstatin
12 October 2001
Stock Commentary - Tokyo
9 August 2001
Japan pharma share prices to August 6
7 August 2001
Sankyo planning to cut 1,000 jobs
6 June 2001
Tokyo pharma stocks week to April 30
2 May 2001
Novartis licenses super statin
26 April 2001
Showing 1-37 of 37 articles
- 1
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
